Capital Performance Advisors LLP Purchases Shares of 100 HCA Healthcare, Inc. (NYSE:HCA)

Capital Performance Advisors LLP purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, Holdings Channel reports. The fund purchased 100 shares of the company’s stock, valued at approximately $41,000.

A number of other large investors also recently modified their holdings of HCA. Financial Strategies Group Inc. increased its holdings in shares of HCA Healthcare by 7.5% in the 3rd quarter. Financial Strategies Group Inc. now owns 20,199 shares of the company’s stock valued at $7,994,000 after acquiring an additional 1,409 shares during the last quarter. AIA Group Ltd lifted its position in shares of HCA Healthcare by 5.3% during the 3rd quarter. AIA Group Ltd now owns 2,000 shares of the company’s stock worth $813,000 after buying an additional 100 shares during the last quarter. Summit Global Investments grew its position in shares of HCA Healthcare by 2.8% in the 3rd quarter. Summit Global Investments now owns 3,287 shares of the company’s stock valued at $1,336,000 after buying an additional 88 shares during the last quarter. Graypoint LLC boosted its stake in HCA Healthcare by 2.9% in the third quarter. Graypoint LLC now owns 1,840 shares of the company’s stock valued at $748,000 after acquiring an additional 51 shares in the last quarter. Finally, Concurrent Investment Advisors LLC increased its position in shares of HCA Healthcare by 26.2% during the third quarter. Concurrent Investment Advisors LLC now owns 2,703 shares of the company’s stock worth $1,099,000 after purchasing an additional 561 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 0.5 %

HCA stock opened at $354.16 on Monday. The business has a fifty day simple moving average of $389.61 and a 200-day simple moving average of $356.29. The company has a market cap of $89.71 billion, a price-to-earnings ratio of 15.90, a PEG ratio of 1.36 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $226.48 and a 52 week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Oppenheimer lifted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Barclays lowered their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.